| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 3.8346 | 11 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 3.84207 | 11 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 3.89251 | 14 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 3.75137 | 9 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 4.02056 | 16 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 4.03265 | 18 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 4.07888 | 19 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 3.85538 | 12 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 3.95161 | 14 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 3.86843 | 12 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 3.73967 | 9 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 4.04028 | 17 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 3.78496 | 10 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 3.80555 | 12 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 3.70943 | 9 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 3.87209 | 13 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 3.92095 | 15 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 3.99175 | 16 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 3.699 | 8 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 4.42995 | 25 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 3.8647 | 12 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 3.76151 | 10 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 3.83094 | 12 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 3.89222 | 13 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 3.90113 | 13 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 4.14033 | 21 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 3.75379 | 9 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 4.0868 | 18 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 4.25403 | 23 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 4.16235 | 19 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 3.77232 | 10 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 3.76335 | 10 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 3.92701 | 13 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 4.19434 | 22 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 3.87103 | 13 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 3.8525 | 13 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 3.6934 | 8 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 3.90563 | 13 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 3.69829 | 8 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 4.36237 | 27 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 3.85121 | 12 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 3.6889 | 8 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 3.87455 | 13 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 3.72093 | 10 |